Amylin/Novo-Nordisk
"We think liraglutide, which is human GLP-1, will emerge as a less potent and less convenient version of LAR,"
My understanding is that Liraglutide does not cause the nausea that is brought on by Byetta for a percentage of users. No nausea might make daily Liraglutide far MORE convenient than weekly injections of Byetta.
Time will tell, I suppose.
Best regards,
Geoff
Market Data 
Markets 
AI
